RBM46
gene geneOn this page
Also known as MGC27016CT68
Summary
RBM46 (RNA binding motif protein 46, HGNC:28401) is a protein-coding gene on chromosome 4q32.1, encoding Probable RNA-binding protein 46 (Q8TBY0). Essential for male and female fertility, playing a crucial role in regulating germ cell development by ensuring the proper progression of meiosis prophase I.
Predicted to enable mRNA binding activity. Predicted to be involved in several processes, including cell cycle switching, mitotic to meiotic cell cycle; meiotic nuclear division; and spermatid differentiation. Predicted to act upstream of or within mRNA stabilization and trophectodermal cell differentiation. Predicted to be located in cytoplasm. Predicted to be active in nucleus.
Source: NCBI Gene 166863 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 46 total
- MANE Select transcript:
NM_144979
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28401 |
| Approved symbol | RBM46 |
| Name | RNA binding motif protein 46 |
| Location | 4q32.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC27016, CT68 |
| Ensembl gene | ENSG00000151962 |
| Ensembl biotype | protein_coding |
| OMIM | 620147 |
| Entrez | 166863 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 4 protein_coding
ENST00000281722, ENST00000510397, ENST00000512640, ENST00000514866
RefSeq mRNA: 3 — MANE Select: NM_144979
NM_001277171, NM_001277173, NM_144979
CCDS: CCDS3790, CCDS64085, CCDS64086
Canonical transcript exons
ENST00000281722 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001002660 | 154796742 | 154796903 |
| ENSE00001002665 | 154797811 | 154798278 |
| ENSE00001002667 | 154798782 | 154799564 |
| ENSE00001210770 | 154827868 | 154828813 |
| ENSE00003842506 | 154781272 | 154781436 |
Expression profiles
Bgee: expression breadth broad, 68 present calls, max score 93.02.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0833 / max 47.8150, expressed in 16 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 50186 | 0.0550 | 14 |
| 50187 | 0.0150 | 3 |
| 50188 | 0.0134 | 5 |
Top tissues by expression
226 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 93.02 | gold quality |
| secondary oocyte | CL:0000655 | 90.77 | gold quality |
| buccal mucosa cell | CL:0002336 | 88.99 | gold quality |
| oocyte | CL:0000023 | 88.41 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 87.90 | gold quality |
| testis | UBERON:0000473 | 79.74 | gold quality |
| right testis | UBERON:0004534 | 78.04 | gold quality |
| left testis | UBERON:0004533 | 77.17 | gold quality |
| oviduct epithelium | UBERON:0004804 | 61.68 | silver quality |
| tibialis anterior | UBERON:0001385 | 60.14 | silver quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| sperm | CL:0000019 | 54.05 | gold quality |
| kidney epithelium | UBERON:0004819 | 53.93 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 53.82 | gold quality |
| upper arm skin | UBERON:0004263 | 53.52 | gold quality |
| pancreatic ductal cell | CL:0002079 | 53.14 | silver quality |
| ileal mucosa | UBERON:0000331 | 52.41 | silver quality |
| deltoid | UBERON:0001476 | 52.38 | gold quality |
| adult organism | UBERON:0007023 | 51.16 | silver quality |
| gall bladder | UBERON:0002110 | 51.13 | gold quality |
| myocardium | UBERON:0002349 | 50.25 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 47.77 | gold quality |
| quadriceps femoris | UBERON:0001377 | 47.62 | gold quality |
| islet of Langerhans | UBERON:0000006 | 47.47 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 47.03 | gold quality |
| cerebellar vermis | UBERON:0004720 | 46.54 | gold quality |
| vastus lateralis | UBERON:0001379 | 45.48 | gold quality |
| ganglionic eminence | UBERON:0004023 | 44.13 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 43.55 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.41 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
63 targeting RBM46, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-3925-3P | 100.00 | 69.95 | 1237 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-196A-1-3P | 99.99 | 72.15 | 2772 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-539-3P | 99.98 | 70.74 | 1616 |
| HSA-MIR-485-3P | 99.98 | 70.68 | 1585 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-3065-5P | 99.97 | 71.56 | 3281 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-141-3P | 99.94 | 72.79 | 2421 |
| HSA-MIR-200A-3P | 99.94 | 72.68 | 2420 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-338-5P | 99.92 | 72.34 | 2951 |
| HSA-MIR-7-1-3P | 99.91 | 71.53 | 4384 |
| HSA-MIR-7-2-3P | 99.91 | 71.40 | 4394 |
| HSA-MIR-1297 | 99.91 | 73.41 | 3162 |
| HSA-MIR-1305 | 99.91 | 71.43 | 3443 |
| HSA-MIR-3529-3P | 99.90 | 73.55 | 3045 |
| HSA-MIR-548D-3P | 99.87 | 70.67 | 4362 |
| HSA-MIR-548BB-3P | 99.86 | 70.58 | 4354 |
Literature-anchored findings (GeneRIF, showing 2)
- RNA binding protein RBM46 regulates mitotic-to-meiotic transition in spermatogenesis. (PMID:36001654)
- Identification of RBM46 as a novel APOBEC1 cofactor for C-to-U RNA-editing activity. (PMID:38708190)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | rbm46 | ENSDARG00000079452 |
| mus_musculus | Rbm46 | ENSMUSG00000033882 |
| rattus_norvegicus | Rbm46 | ENSRNOG00000025823 |
Paralogs (36): DAZAP1 (ENSG00000071626), CIRBP (ENSG00000099622), RBM23 (ENSG00000100461), RBM3 (ENSG00000102317), NCL (ENSG00000115053), TIA1 (ENSG00000116001), HNRNPA2B1 (ENSG00000122566), RBM19 (ENSG00000122965), RBM39 (ENSG00000131051), MSI1 (ENSG00000135097), HNRNPA1 (ENSG00000135486), HNRNPD (ENSG00000138668), HNRNPA1L2 (ENSG00000139675), RBMX (ENSG00000147274), A1CF (ENSG00000148584), TIAL1 (ENSG00000151923), HNRNPDL (ENSG00000152795), MSI2 (ENSG00000153944), RBM47 (ENSG00000163694), RBMY1F (ENSG00000169800), HNRNPA3 (ENSG00000170144), RBMXL2 (ENSG00000170748), RBM4B (ENSG00000173914), RBM4 (ENSG00000173933), RBMXL3 (ENSG00000175718), HNRNPA0 (ENSG00000177733), TRNAU1AP (ENSG00000180098), HNRNPAB (ENSG00000197451), RBMXL1 (ENSG00000213516), HNRNPA1L3 (ENSG00000224578), RBMY1J (ENSG00000226941), RBMY1A1 (ENSG00000234414), RBMY1E (ENSG00000242389), RBMY1B (ENSG00000242875), RBMY1D (ENSG00000244395), DND1 (ENSG00000256453)
Protein
Protein identifiers
Probable RNA-binding protein 46 — Q8TBY0 (reviewed: Q8TBY0)
Alternative names: Cancer/testis antigen 68, RNA-binding motif protein 46
All UniProt accessions (2): Q8TBY0, D6RF41
UniProt curated annotations — full annotation on UniProt →
Function. Essential for male and female fertility, playing a crucial role in regulating germ cell development by ensuring the proper progression of meiosis prophase I. Regulates mitotic-to-meiotic transition in spermatogenesis by forming a complex with MEIOC and YTHDC2 which recognizes and down-regulates mitotic transcripts for a successful meiotic entry. Required for normal synaptonemal complex formation during meiosis, binding meiotic cohesin subunit mRNAs containing GCCUAU/GUUCGA motifs in their 3’UTRs regions and positively regulating their translation. Required for spermatogonial differentiation in both developing and adult testis.
Subunit / interactions. Interacts with YTHDC2, MEIOC, MOV10, CNOT6L, DDX4, UPF1 and PABPC1.
Subcellular location. Cytoplasm.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8TBY0-1 | 1 | yes |
| Q8TBY0-2 | 2 | |
| Q8TBY0-3 | 3 |
RefSeq proteins (3): NP_001264100, NP_001264102, NP_659416* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000504 | RRM_dom | Domain |
| IPR006535 | HnRNP_R/Q_splicing_fac | Family |
| IPR012677 | Nucleotide-bd_a/b_plait_sf | Homologous_superfamily |
| IPR034434 | RBM46_RRM1 | Domain |
| IPR034435 | RBM46_RRM2 | Domain |
| IPR035979 | RBD_domain_sf | Homologous_superfamily |
| IPR044462 | RBM46_DSR | Domain |
| IPR047837 | RBM46_RRM3 | Domain |
Pfam: PF00076, PF14709
UniProt features (6 total): domain 3, splice variant 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8TBY0-F1 | 73.43 | 0.43 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 126 (showing top):
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_UP, GOBP_POSITIVE_REGULATION_OF_REPRODUCTIVE_PROCESS, GOBP_EMBRYO_DEVELOPMENT_ENDING_IN_BIRTH_OR_EGG_HATCHING, chr4q32, GOBP_REGULATION_OF_MRNA_CATABOLIC_PROCESS, GOBP_OOGENESIS, GOBP_MACROMOLECULE_CATABOLIC_PROCESS, GOBP_MALE_GAMETE_GENERATION, GOBP_BLASTOCYST_FORMATION, GOBP_REGULATION_OF_MEIOTIC_CELL_CYCLE, GOBP_POST_TRANSCRIPTIONAL_REGULATION_OF_GENE_EXPRESSION, GOBP_POSITIVE_REGULATION_OF_MEIOTIC_CELL_CYCLE, GOBP_IN_UTERO_EMBRYONIC_DEVELOPMENT, GOBP_ORGANELLE_FISSION, GOBP_REGULATION_OF_CATABOLIC_PROCESS
GO Biological Process (11): trophectodermal cell differentiation (GO:0001829), male meiotic nuclear division (GO:0007140), female meiotic nuclear division (GO:0007143), spermatogenesis (GO:0007283), mRNA stabilization (GO:0048255), oogenesis (GO:0048477), spermatid differentiation (GO:0048515), cell cycle switching, mitotic to meiotic cell cycle (GO:0051728), cell differentiation (GO:0030154), meiotic cell cycle (GO:0051321), negative regulation of mRNA catabolic process (GO:1902373)
GO Molecular Function (5): mRNA binding (GO:0003729), enzyme-substrate adaptor activity (GO:0140767), nucleic acid binding (GO:0003676), RNA binding (GO:0003723), protein binding (GO:0005515)
GO Cellular Component (3): nucleus (GO:0005634), cytoplasm (GO:0005737), apolipoprotein B mRNA editing enzyme complex (GO:0030895)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| meiotic nuclear division | 3 |
| cell differentiation | 2 |
| male gamete generation | 2 |
| meiotic cell cycle | 2 |
| female gamete generation | 2 |
| developmental process involved in reproduction | 2 |
| binding | 2 |
| blastocyst formation | 1 |
| regulation of mRNA stability | 1 |
| RNA stabilization | 1 |
| negative regulation of mRNA catabolic process | 1 |
| germ cell development | 1 |
| spermatogenesis | 1 |
| cellular process involved in reproduction in multicellular organism | 1 |
| negative regulation of mitotic cell cycle | 1 |
| positive regulation of meiotic cell cycle | 1 |
| cell cycle switching | 1 |
| cellular developmental process | 1 |
| cell cycle | 1 |
| sexual reproduction | 1 |
| reproductive process | 1 |
| mRNA catabolic process | 1 |
| positive regulation of gene expression | 1 |
| regulation of mRNA catabolic process | 1 |
| negative regulation of RNA catabolic process | 1 |
| negative regulation of mRNA metabolic process | 1 |
| RNA binding | 1 |
| protein-macromolecule adaptor activity | 1 |
| nucleic acid binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| mRNA editing complex | 1 |
| nuclear protein-containing complex | 1 |
Protein interactions and networks
STRING
848 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RBM46 | ZFYVE28 | Q9HCC9 | 690 |
| RBM46 | ZNF678 | Q5SXM1 | 669 |
| RBM46 | EXD3 | Q8N9H8 | 646 |
| RBM46 | DMRTB1 | Q96MA1 | 606 |
| RBM46 | CPXCR1 | Q8N123 | 571 |
| RBM46 | CCDC110 | Q8TBZ0 | 507 |
| RBM46 | CATSPER4 | Q7RTX7 | 493 |
| RBM46 | ARMC9 | Q7Z3E5 | 475 |
| RBM46 | HSPBAP1 | Q96EW2 | 470 |
| RBM46 | CTSO | P43234 | 460 |
| RBM46 | TMEM225 | Q6GV28 | 442 |
| RBM46 | MEIOC | A2RUB1 | 441 |
| RBM46 | CTDSP2 | O14595 | 440 |
| RBM46 | GXYLT1 | Q4G148 | 437 |
| RBM46 | CT62 | P0C5K7 | 435 |
| RBM46 | ZNF687 | Q8N1G0 | 435 |
IntAct
31 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| RBPMS2 | RBM46 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FOXH1 | RBM46 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBM46 | GORASP2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBM46 | CHAT | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBM46 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| RBM46 | FGFR3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBM46 | GSN | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBM46 | HRAS | psi-mi:“MI:0915”(physical association) | 0.560 |
| TARDBP | RBM46 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBM46 | RBM47 | psi-mi:“MI:0915”(physical association) | 0.500 |
| RBPMS | RBM46 | psi-mi:“MI:0915”(physical association) | 0.370 |
| RBM47 | IGF2BP3 | psi-mi:“MI:0914”(association) | 0.350 |
| RBM46 | RBPMS2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| FOXH1 | RBM46 | psi-mi:“MI:0915”(physical association) | 0.000 |
| RBM46 | GORASP2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (13): RBM46 (Co-fractionation), RBM46 (Two-hybrid), RBM46 (Affinity Capture-MS), RBM46 (Two-hybrid), FOXH1 (Two-hybrid), RBPMS2 (Two-hybrid), RBM47 (Affinity Capture-MS), RBM46 (Affinity Capture-MS), RBM46 (Two-hybrid), RBM46 (Affinity Capture-MS), RBM46 (Cross-Linking-MS (XL-MS)), RBM46 (Affinity Capture-MS), RBM46 (Affinity Capture-MS)
ESM2 similar proteins: A0A0R4IEW8, A4QNI8, B5DF91, O01671, O09032, O17310, O61374, O64380, O95758, O97018, P16914, P19339, P26378, P26599, P42731, P70372, P86049, Q12926, Q14576, Q15717, Q1JQ73, Q24668, Q28FX0, Q28GD4, Q29099, Q5R9H4, Q5R9Z6, Q5U259, Q5YD48, Q60899, Q60900, Q61701, Q6DEY7, Q6GLB5, Q6GR16, Q6YZW2, Q7SZT7, Q8CH84, Q8GZ26, Q8LFS6
Diamond homologs: A0A8M1NHK4, A0AV96, A0JM51, A4FV72, A4QUF0, A8WLV5, O01671, O04425, O43040, O43390, O60506, P28659, P33240, P86049, Q08BH5, Q08E07, Q0P4R6, Q0V9L3, Q10B98, Q14498, Q28HE9, Q2HJG2, Q2UK72, Q3UEB3, Q4QQT3, Q4R2Z0, Q4R535, Q5B630, Q5EA36, Q5R469, Q5R5P4, Q5R723, Q5R9H4, Q5RC41, Q5RC80, Q5RDA3, Q5SZQ8, Q5YD48, Q66H68, Q6DCB7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
46 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 41 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1080 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:154796735:A:AG | acceptor_gain | 1.0000 |
| 4:154796740:A:AG | acceptor_gain | 1.0000 |
| 4:154796740:AG:A | acceptor_gain | 1.0000 |
| 4:154796741:G:A | acceptor_gain | 1.0000 |
| 4:154796741:G:GA | acceptor_gain | 1.0000 |
| 4:154796741:GGA:G | acceptor_gain | 1.0000 |
| 4:154796741:GGAA:G | acceptor_gain | 1.0000 |
| 4:154796741:GGAAC:G | acceptor_gain | 1.0000 |
| 4:154796868:A:T | donor_gain | 1.0000 |
| 4:154796881:G:GT | donor_gain | 1.0000 |
| 4:154796882:A:T | donor_gain | 1.0000 |
| 4:154796900:CCAG:C | donor_loss | 1.0000 |
| 4:154796901:CAG:C | donor_loss | 1.0000 |
| 4:154796903:GG:G | donor_loss | 1.0000 |
| 4:154796904:G:T | donor_loss | 1.0000 |
| 4:154797806:TTCA:T | acceptor_loss | 1.0000 |
| 4:154797807:TCAG:T | acceptor_loss | 1.0000 |
| 4:154797808:CAG:C | acceptor_loss | 1.0000 |
| 4:154798776:TTACA:T | acceptor_loss | 1.0000 |
| 4:154798777:TACA:T | acceptor_loss | 1.0000 |
| 4:154798779:CAGG:C | acceptor_loss | 1.0000 |
| 4:154798780:A:AC | acceptor_loss | 1.0000 |
| 4:154798780:A:AG | acceptor_gain | 1.0000 |
| 4:154798781:G:GG | acceptor_gain | 1.0000 |
| 4:154798781:G:GT | acceptor_loss | 1.0000 |
| 4:154798781:GGAAC:G | acceptor_gain | 1.0000 |
| 4:154820354:T:A | acceptor_gain | 1.0000 |
| 4:154781434:GGG:G | donor_gain | 0.9900 |
| 4:154781435:GGG:G | donor_gain | 0.9900 |
| 4:154796736:T:G | acceptor_gain | 0.9900 |
AlphaMissense
3524 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 4:154796873:G:A | G41R | 1.000 |
| 4:154796873:G:C | G41R | 1.000 |
| 4:154796874:G:A | G41E | 1.000 |
| 4:154796874:G:T | G41V | 1.000 |
| 4:154796877:A:C | Q42P | 1.000 |
| 4:154796878:A:C | Q42H | 1.000 |
| 4:154796878:A:T | Q42H | 1.000 |
| 4:154796880:G:C | R43T | 1.000 |
| 4:154796880:G:T | R43M | 1.000 |
| 4:154796881:G:C | R43S | 1.000 |
| 4:154796881:G:T | R43S | 1.000 |
| 4:154797845:A:C | E62D | 1.000 |
| 4:154797845:A:T | E62D | 1.000 |
| 4:154797847:T:A | V63D | 1.000 |
| 4:154797849:T:A | F64I | 1.000 |
| 4:154797849:T:C | F64L | 1.000 |
| 4:154797849:T:G | F64V | 1.000 |
| 4:154797850:T:C | F64S | 1.000 |
| 4:154797850:T:G | F64C | 1.000 |
| 4:154797851:T:A | F64L | 1.000 |
| 4:154797851:T:G | F64L | 1.000 |
| 4:154797853:T:A | V65E | 1.000 |
| 4:154797855:G:A | G66R | 1.000 |
| 4:154797855:G:C | G66R | 1.000 |
| 4:154797856:G:A | G66E | 1.000 |
| 4:154797862:T:A | I68K | 1.000 |
| 4:154797862:T:G | I68R | 1.000 |
| 4:154797889:T:C | L77S | 1.000 |
| 4:154797912:G:T | G85W | 1.000 |
| 4:154797913:G:A | G85E | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000059366 (4:154808517 G>A), RS1000195355 (4:154826305 A>G), RS1000207281 (4:154802767 T>G), RS1000284168 (4:154782584 A>G), RS1000349626 (4:154794256 CT>C), RS1000358783 (4:154795883 T>C), RS1000416226 (4:154788160 T>G), RS1000480784 (4:154801944 A>C), RS1000488727 (4:154802368 A>G), RS1000521680 (4:154820029 G>C), RS1000540584 (4:154804019 G>A,T), RS1000592775 (4:154804195 G>A), RS1000647799 (4:154797231 A>C), RS1000716397 (4:154808270 TTA>T), RS1000765038 (4:154790943 A>C,G)
Disease associations
OMIM: gene MIM:620147 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004735_14 | Epstein-Barr virus copy number in lymphoblastoid cell lines | 7.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, increases expression, increases methylation | 3 |
| aristolochic acid I | decreases expression | 1 |
| 2,6-dichloro-(1,4)benzoquinone | decreases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Copper | affects cotreatment, decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): Epstein-Barr virus infection